ArticleThe Lancet regional health. Southeast Asia2025

Efficacy and safety of a 3-day once-daily regimen of oral nafithromycin in comparison to oral moxifloxacin for the treatment of community-acquired bacterial pneumonia in adults: a phase III, randomized, double-blind controlled trial.

Himanshu Pophale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.